guardant health investors

Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant Health has a joint venture with Softbank to take its products internationally. Investors that wish to register for the company’s conference call can do so using this link. Media inquiries: © Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. IBD Subscribers also enjoy ongoing investor training and support. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. Realtime quote and/or trade prices are not sourced from all markets. That was above its estimated range of 15 to 17. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. {"@context":"https:\/\/","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Bellwether Bio acquired by Guardant Health, Stock ticker symbol (e.g. WhatsApp acquired by Facebook). Guardant Health is registered under the ticker NASDAQ:GH . The Guardant Health IPO priced 12.5 million shares at 19. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Guardant was founded in 2012 in Redwood City, Calif. Investor Contact: Carrie Mendivil Media Contact: Anna Czene Courtney Carroll Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Soon, it could detect cancer earlier than ever before. The company operates in delivering … Analysts expect the company to announce earnings of ($0.34) per share for the quarter. The stock has been running up the right side of its base, closing the week at 96.14. Guardant Health General Information Description. Telephone: 855.698.8887 Fax: 888.974.4258. Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. The stock continued to move up. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. Guardant Health stock is working on a cup base with a 100.10 entry point. Data source: investor presentation. Guardant Health has raised a total of $550M in funding over 8 rounds. Guardant shares closed at 32.20, up 69.5% on the stock market today. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. The Guardant Health IPO listed on the Nasdaq under the ticker GH. © 2000-2020 Investor's Business Daily, Inc. All rights reserved, We’ve got 12 big deals on premium IBD products! Check out today’s deal before it expires…. Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. Privacy Policy & Terms of Use. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Guardant Health last raised $360M false. Shares opened at 27.75 for an initial gain of 46%. Which types of acquisition does this organization make most frequently. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant Health, Inc. Reconciliation of Net Loss Attributable to Guardant Health, Inc. Common Stockholders (1) to Non-GAAP Adjusted EBITDA (unaudited) (in thousands) Three Months Ended September 30, Guardant Health is still in its infancy and has a huge runway of growth with an estimated revenue of just US$200 million for 2019. International opportunity. Load up your sleigh and save hundreds on IBD’s Online Courses! Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. Register now! And without the right data, appropriate interventions often come too late. Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. Which Companies Are Now Outperforming 95% Of All Stocks? Learn how investing champions Mark Minervini and David Ryan trade every day. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Cancer is data starved. Get market updates, educational videos, webinars, and stock analysis. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Which funding types raised the most money? Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Amazon, Apple pressured on a China report. Illumina, Exact Sciences deals heating... 11/13/2020 How much funding has this organization raised over time? Do the … In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Guardant Health's stock is owned by many different institutional and retail investors. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 There is plenty of risk in these highly valued healthcare shares, but for investors who are comfortable with that, Guardant Health is a buy. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Here Are The 6 Stocks That Will Shake Up The Nasdaq. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. *Real-time prices by Nasdaq Last Sale. Guardant Health went on the Nasdaq yesterday under the symbol GH. Guardant Health doesn't appear a compelling earnings-beat candidate. Get these newsletters delivered to your inbox & more info about our products & services. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Guardant Health Inc is a precision oncology company. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.

Antonim Dari Prominen, Bangalore To Wayanad Ksrtc, City Of Charleston Gis, What Is My Color Season, School Psychology Praxis App, Hard Drive Not Showing Up In Bios Reddit, Colored Burlap Rolls Canada,

Lämna ett svar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *